Published in Gene Therapy Weekly, April 4th, 2002
The antigen is carcinoembryonic antigen (CEA), which is commonly expressed by a wide range of cancers, including 50-90% of colorectal, gastric, and pancreatic cancers, lung and breast cancers. These CEA expressing cancers represent the majority of cancer deaths worldwide.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.